Overview
Home // Formulation Development // Overview
Enaltec has positioned itself in offering a spectrum of Contract Research and Development Services for the generic formulations across the globe through its two R&D sites viz. Enaltec Pharma Research and Enaltec Formulation Labs. The objective is to act as an adept neutral R & D partner to big pharmaceutical generic companies with a sole intention to develop and create an intellectual property for the client. All the developmental activities carried out at Enaltec are managed and conducted intelligently, scientifically, and methodically to offer the best service and on time.
Enaltec has the capability to offer the full spectrum of capabilities in order to achieve speed to the market and the services include ranging from API and formulation development to the coordination of outsourced services such as bioequivalence studies and contract manufacturing, at locations where we enjoy a preferred customer status. Our expertise covers the following development range:
Generics and complex generics product development in Oral Solids, Oral Liquids, Dermatology, Parenteral & Lyophilized Injectables, Ophthalmic & Potent Drugs (oncology and hormones)
505(b) 2 developments + Lifecycle management
Non-infringing and Para IV formulation development
First-to-file formulation development
Drug re-purposing
NCEs
